Summary

North America inflation device market is expected to reach USD 524.79 million by 2032, from USD 353.62 million in 2024, growing at the CAGR of 5.1% in the forecast period of 2025 to 2032.
Market Segmentation:
North America Inflation Device Market, By Type (Analog Inflation Device and Digital Inflation Device), Capacity (20ml Inflation Device, 25ml Inflation Device, 30ml Inflation Device, and 60ml Inflation Device), Application (Interventional Cardiology, Peripheral Vascular Procedures, Interventional Radiology, Urological Procedures, Gastroenterological Procedures, and Others), Pressure (30 atm, 40 atm, 55 atm, and Others), Function (Stent Deployment and Fluid Delivery), End User (Hospitals, Interventional Laboratories, and Clinics), Distribution Channel (Direct Tender, Retail Sales, and Third Party Distributors), Country (U.S., Canada, and Mexico) – Industry Trends and Forecast to 2032
Overview of North America Inflation Device Market Dynamics:
Driver
• Rising case of cardiovascular diseases
Restraint
• High cost of advanced inflation devices
Opportunity
• Expanding access to interventional care in emerging markets
Market Players
The key market players for North America inflation device market are listed below:
• Boston Scientific Corporation
• BD
• B. Braun Interventional Systems Inc
• Olympus Corporation
• Merit Medical Systems
• Medtronic
• Teleflex Incorporated
• CONMED Corporation
• Integra LifeSciences Corporation
• Vygon SAS
• Atrion Medical
• Cook
• Advin Health Care
• US Endovascular, LLC.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF THE NORTH AMERICA INFLATION DEVICE MARKET 28
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 30
2 MARKET SEGMENTATION 32
2.1 MARKETS COVERED 32
2.2 GEOGRAPHICAL SCOPE 33
2.3 YEARS CONSIDERED FOR THE STUDY 34
2.4 CURRENCY AND PRICING 34
2.5 DBMR TRIPOD DATA VALIDATION MODEL 35
2.6 MULTIVARIATE MODELLING 38
2.7 TYPE LIFELINE CURVE 38
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.9 DBMR MARKET POSITION GRID 40
2.10 VENDOR SHARE ANALYSIS 41
2.11 MARKET END USER COVERAGE GRID 42
2.12 SECONDARY SOURCES 43
2.13 ASSUMPTIONS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 51
4.1 PESTAL ANALYSIS 52
4.2 COST ANALYSIS BREAKDOWN: NORTH AMERICA INFLATION DEVICE MARKET 53
4.3 HEALTHCARE ECONOMY 54
4.3.1 HEALTHCARE EXPENDITURE 54
4.3.2 CAPITAL EXPENDITURE (CAPEX) 54
4.3.3 CAPEX TRENDS 54
4.3.4 CAPEX ALLOCATION 54
4.3.5 FUNDING SOURCES 54
4.3.6 INDUSTRY BENCHMARKS 54
4.3.7 HEALTHCARE EXPENDITURE RATIO IN OVERALL GDP 54
4.3.8 HEALTHCARE SYSTEM STRUCTURE 55
4.3.9 GOVERNMENT POLICIES 55
4.3.10 ECONOMIC DEVELOPMENT 55
4.4 INDUSTRY INSIGHTS 56
4.5 PENETRATION AND GROWTH PROSPECT MAPPING: NORTH AMERICA INFLATION DEVICE MARKET 59
4.6 KEY PRICING STRATEGIES: NORTH AMERICA INFLATION DEVICE MARKET 61
4.7 INNOVATION TRACKER AND STRATEGIC ANALYSIS: NORTH AMERICA INFLATION DEVICE MARKET 63
4.8 OPPORTUNITY MAP ANALYSIS. 66
4.9 REIMBURSEMENT FRAMEWORK – NORTH AMERICA INFLATION DEVICE MARKET 68
4.10 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR. 70
4.10.1 NORTH AMERICA VS. REGIONAL TARIFF STRUCTURES 70
4.10.2 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY 70
4.10.3 TARIFF REGULATIONS IN KEY MARKETS 70
4.11 TARIFFS ON MEDICAL DEVICES & EQUIPMENT 71
4.11.1 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT 71
4.11.2 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY 71
4.11.3 CASE STUDIES OF TARIFF CHANGES AFFECTING THE INDUSTRY 71
4.11.4 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES 71
4.11.5 TARIFF EXEMPTIONS AND INCENTIVES 71
4.11.6 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES 71
4.11.7 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN 71
4.11.8 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS 72
4.12 TECHNOLOGY ROADMAP: NORTH AMERICA INFLATION DEVICE MARKET 73
4.13 VALUE CHAIN ANALYSIS: NORTH AMERICA INFLATION DEVICE MARKET 74
5 REGULATORY COMPLIANCE: NORTH AMERICA INFLATION DEVICE MARKET 76
5.1 REGULATORY AUTHORITIES 76
5.2 REGULATORY SUBMISSIONS 77
5.3 INTERNATIONAL HARMONIZATION 77
5.4 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 78
5.5 REGULATORY CHALLENGES AND STRATEGIES 78
6 MARKET OVERVIEW 79
6.1 DRIVERS 81
6.1.1 RISING CASE OF CARDIOVASCULAR DISEASES 81
6.1.2 WIDE RANGE OF APPLICATIONS OF INFLATION DEVICES 81
6.1.3 INCREASING NUMBER OF MINIMALLY INVASIVE SURGERIES 82
6.1.4 AGING POPULATION AND CHRONIC DISEASE BURDEN 82
6.2 RESTRAINTS 84
6.2.1 HIGH COST OF ADVANCED INFLATION DEVICES 84
6.2.2 MAINTENANCE AND TRAINING REQUIREMENTS 84
6.3 OPPORTUNITIES 85
6.3.1 EXPANDING ACCESS TO INTERVENTIONAL CARE IN EMERGING MARKETS 85
6.3.2 TECHNOLOGICAL ADVANCEMENTS IN INFLATION DEVICES 85
6.3.3 STRATEGIC PARTNERSHIPS AND ACQUISITIONS 86
6.4 CHALLENGES 87
6.4.1 LOW-COST ALTERNATIVES OF INFLATION DEVICES 87
6.4.2 SHORTAGE OF HEALTHCARE PROFESSIONALS LIMITING DEVICE UTILIZATION 87
7 NORTH AMERICA INFLATION DEVICE MARKET, BY TYPE 89
7.1 OVERVIEW 90
7.2 ANALOG INFLATION DEVICE 93
7.2.1 20ML INFLATION DEVICE 93
7.2.2 25ML INFLATION DEVICE 93
7.2.3 30ML INFLATION DEVICE 94
7.2.4 60ML INFLATION DEVICE 94
7.3 DIGITAL INFLATION DEVICE 94
7.3.1 30ML INFLATION DEVICE 95
7.3.2 25ML INFLATION DEVICE 95
7.3.3 20ML INFLATION DEVICE 95
7.3.4 60ML INFLATION DEVICE 95
8 NORTH AMERICA INFLATION DEVICE MARKET, BY CAPACITY 96
8.1 OVERVIEW 97
8.2 20ML INFLATION DEVICE 100
8.3 25ML INFLATION DEVICE 100
8.4 30ML INFLATION DEVICE 101
8.5 60ML INFLATION DEVICE 101
9 NORTH AMERICA INFLATION DEVICE MARKET, BY PRESSURE 102
9.1 OVERVIEW 103
9.2 30 ATM 106
9.3 40 ATM 106
9.4 55 ATM 107
9.5 OTHERS 107
10 NORTH AMERICA INFLATION DEVICE MARKET, BY APPLICATION 108
10.1 OVERVIEW 109
10.2 INTERVENTIONAL CARDIOLOGY 112
10.3 PERIPHERAL VASCULAR PROCEDURES 112
10.4 INTERVENTIONAL RADIOLOGY 113
10.5 UROLOGICAL PROCEDURES 113
10.6 GASTROENTEROLOGICAL PROCEDURES 114
10.7 OTHERS 114
11 NORTH AMERICA INFLATION DEVICE MARKET, BY DISTRIBUTION CHANNEL 115
11.1 OVERVIEW 116
11.2 DIRECT TENDER 119
11.3 RETAIL SALES 119
11.4 THIRD PARTY DISTRIBUTORS 120
12 NORTH AMERICA INFLATION DEVICE MARKET, BY END USER 121
12.1 OVERVIEW 122
12.2 HOSPITALS 125
12.3 INTERVENTIONAL LABORATORIES 125
12.4 CLINICS 126
13 NORTH AMERICA INFLATION DEVICE MARKET, BY FUNCTION 127
13.1 OVERVIEW 128
13.2 STENT DEPLOYMENT 131
13.3 FLUID DELIVERY 131
14 NORTH AMERICA INFLATION DEVICE MARKET, BY REGION 132
14.1 NORTH AMERICA 135
14.1.1 U.S. 139
14.1.2 CANADA 142
14.1.3 MEXICO 145
15 NORTH AMERICA INFLATION DEVICE MARKET, COMPANY LANDSCAPE 148
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 148
16 SWOT ANALYSIS 149
17 COMPANY PROFILE 150
17.1 BOSTON SCIENTIFIC CORPORATION 150
17.1.1 COMPANY SNAPSHOT 150
17.1.2 REVENUE ANALYSIS 151
17.1.3 COMPANY SHARE ANALYSIS 151
17.1.4 PRODUCT PORTFOLIO 152
17.1.5 RECENT DEVELOPMENT 152
17.2 BD 153
17.2.1 COMPANY SNAPSHOT 153
17.2.2 REVENUE ANALYSIS 153
17.2.3 COMPANY SHARE ANALYSIS 154
17.2.4 PRODUCT PORTFOLIO 154
17.2.5 RECENT DEVELOPMENT 154
17.3 B. BRAUN INTERVENTIONAL SYSTEMS INC. 155
17.3.1 COMPANY SNAPSHOT 155
17.3.2 COMPANY SHARE ANALYSIS 155
17.3.3 PRODUCT PORTFOLIO 156
17.3.4 RECENT DEVELOPMENT 157
17.4 OLYMPUS CORPORATION 158
17.4.1 COMPANY SNAPSHOT 158
17.4.2 REVENUE ANALYSIS 158
17.4.3 COMPANY SHARE ANALYSIS 159
17.4.4 PRODUCT PORTFOLIO 159
17.4.5 RECENT DEVELOPMENT 160
17.5 MERIT MEDICAL SYSTEMS 161
17.5.1 COMPANY SNAPSHOT 161
17.5.2 REVENUE ANALYSIS 161
17.5.3 COMPANY SHARE ANALYSIS 162
17.5.4 PRODUCT PORTFOLIO 162
17.5.5 RECENT DEVELOPMENTS 163
17.6 ADVANCED LIFESCIENCES PVT. LTD. 164
17.6.1 COMPANY SNAPSHOT 164
17.6.2 PRODUCT PORTFOLIO 164
17.6.3 RECENT DEVELOPMENT 166
17.7 ADVIN HEALTH CARE 167
17.7.1 COMPANY SNAPSHOT 167
17.7.2 PRODUCT PORTFOLIO 167
17.7.3 RECENT DEVELOPMENT 167
17.8 ATRION MEDICAL 168
17.8.1 COMPANY SNAPSHOT 168
17.8.2 REVENUE ANALYSIS 168
17.8.3 PRODUCT PORTFOLIO 169
17.8.4 RECENT DEVELOPMENT 169
17.9 CONMED CORPORATION 170
17.9.1 COMPANY SNAPSHOT 170
17.9.2 REVENUE ANALYSIS 170
17.9.3 PRODUCT PORTFOLIO 171
17.9.4 RECENT DEVELOPMENT 171
17.10 COOK 172
17.10.1 COMPANY SNAPSHOT 172
17.10.2 PRODUCT PORTFOLIO 172
17.10.3 RECENT NEWS 172
17.11 ELITE MEDTEK(JIANGSU) CO., LTD 173
17.11.1 COMPANY SNAPSHOT 173
17.11.2 PRODUCT PORTFOLIO 173
17.11.3 RECENT DEVELOPMENT 173
17.12 INTEGRA LIFESCIENCES CORPORATION 174
17.12.1 COMPANY SNAPSHOT 174
17.12.2 REVENUE ANALYSIS 174
17.12.3 PRODUCT PORTFOLIO 175
17.12.4 RECENT DEVELOPMENT 176
17.13 MEDORAH MEDITEK PVT. LTD. 177
17.13.1 COMPANY SNAPSHOT 177
17.13.2 PRODUCT PORTFOLIO 177
17.13.3 RECENT DEVELOPMENT 177
17.14 MEDTRONIC 178
17.14.1 COMPANY SNAPSHOT 178
17.14.2 REVENUE ANALYSIS 178
17.14.3 PRODUCT PORTFOLIO 179
17.14.4 RECENT DEVELOPMENT 179
17.15 SMT 180
17.15.1 COMPANY SNAPSHOT 180
17.15.2 PRODUCT PORTFOLIO 180
17.15.3 RECENT DEVELOPMENT 180
17.16 SPECTRUM MEDTECH PVT. LTD. 181
17.16.1 COMPANY SNAPSHOT 181
17.16.2 PRODUCT PORTFOLIO 181
17.16.3 RECENT DEVELOPMENT 181
17.17 SURETECH MEDICAL INC. 182
17.17.1 COMPANY SNAPSHOT 182
17.17.2 PRODUCT PORTFOLIO 182
17.17.3 RECENT DEVELOPMENT 182
17.18 TELEFLEX INCORPORATED 183
17.18.1 COMPANY SNAPSHOT 183
17.18.2 REVENUE ANALYSIS 183
17.18.3 PRODUCT PORTFOLIO 184
17.18.4 RECENT DEVELOPMENT 184
17.19 US ENDOVASCULAR, LLC. 185
17.19.1 COMPANY SNAPSHOT 185
17.19.2 PRODUCT PORTFOLIO 185
17.19.3 RECENT DEVELOPMENT 186
17.20 VYGON SAS 187
17.20.1 COMPANY SNAPSHOT 187
17.20.2 PRODUCT PORTFOLIO 187
17.20.3 RECENT DEVELOPMENT 187
18 QUESTIONNAIRE 188
19 RELATED REPORTS 192